Simona DiGiambenedetto
Overview
Explore the profile of Simona DiGiambenedetto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Capetti A, Atzori C, Cossu M, Ciccullo A, Restelli S, Piscaglia M, et al.
Open Forum Infect Dis
. 2019 Mar;
6(2):ofz044.
PMID: 30815508
No abstract available.
2.
Capetti A, Orofino G, Paladini L, Sterrantino G, DiGiambenedetto S, De Socio G, et al.
AIDS
. 2018 Apr;
32(8):1083-1084.
PMID: 29698323
No abstract available.
3.
Raffetti E, Donato F, Casari S, Castelnuovo F, Sighinolfi L, Bandera A, et al.
BMC Infect Dis
. 2017 Mar;
17(1):193.
PMID: 28264665
Background: Two biomarkers, the neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR), have been shown to be indicative of systemic inflammation and predictive of mortality in general...
4.
Torti C, Raffetti E, Donato F, Castelli F, Maggiolo F, Angarano G, et al.
Int J Epidemiol
. 2015 Oct;
46(2):e12.
PMID: 26445966
No abstract available.
5.
Raffetti E, Donato F, Pezzoli C, DiGiambenedetto S, Bandera A, Di Pietro M, et al.
J Acquir Immune Defic Syndr
. 2015 Jul;
69(5):585-92.
PMID: 26167619
Background: Recently, some systemic inflammation-based biomarkers have been demonstrated useful for predicting risk of death in patients with solid cancer independently of tumor characteristics. This study aimed to investigate the...
6.
Raffetti E, Donato F, Castelnuovo F, Ladisa N, Paraninfo G, Di Filippo E, et al.
J Transl Med
. 2015 Apr;
13:89.
PMID: 25886534
Background: The systemic inflammatory response has been postulated as having prognostic significance in a wide range of different cancer types. We aimed to assess the prognostic role of inflammatory markers...
7.
Fortuna S, Fabbiani M, DiGiambenedetto S, Ragazzoni E, Lisi L, Cauda R, et al.
Pharmacology
. 2013 Jul;
92(1-2):43-8.
PMID: 23887354
Therapeutic drug monitoring of raltegravir Ctrough levels was carried out in the setting of the Raltegravir Switch for Toxicity or Adverse events (RASTA) trial, a randomized pilot study exploring a...